The role of glutamine in cancer cell growth Rapidly proliferating cancer cells take up glutamine from plasma via various amino acid transporters, and then it is converted to glutamate in the mitochondria by the two forms of glutaminase: kidney-type glutaminase (GLS)1 and liver-type GLS2 8
as of May 2026 is clinical trial enrollment FDA-approved alternatives exist (semaglutide, tirzepatide) with established compounding and dosing pathways and substantial clinical data Self-sourcing research peptides for human use is not safe and carries identity, purity, and contamination risks If you are a clinician: Patient questions about retatrutide source verification are increasing
And its here where the concept of nasally administering BPC-157 attracted the attention of curious biohackers
Ricciardi MR, Decandia S, Santinelli S, Gregorj C, De Cave F, Scerpa MC, Bergamo P, Libotte F, De Benedictis C, Vitale A, Petrucci MT, Konopleva M, Andreeff M , Milella M, Foa R, Tafuri A
Biosynthesis of leukotriene B4
There are currently no randomized, controlled clinical trials examining the effects of BPC-157 in humans
